Shares of Vital Therapies (NASDAQ:VTL) hit a new 52-week high on Friday . The stock traded as high as $15.00 and last traded at $13.92, with a volume of 339712 shares changing hands. The stock had previously closed at $14.05.

Separately, ValuEngine upgraded XPO Logistics from a “strong sell” rating to a “sell” rating in a research report on Thursday, April 4th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $12.00.

The stock’s fifty day moving average is $8.92.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bank of Montreal Can grew its holdings in Vital Therapies by 1,065.5% in the first quarter. Bank of Montreal Can now owns 5,000 shares of the company’s stock valued at $39,000 after purchasing an additional 4,571 shares during the period. SG Americas Securities LLC boosted its stake in shares of Vital Therapies by 30.6% in the first quarter. SG Americas Securities LLC now owns 260,743 shares of the company’s stock worth $51,000 after acquiring an additional 61,098 shares during the last quarter. Two Sigma Investments LP boosted its stake in shares of Vital Therapies by 42.5% in the fourth quarter. Two Sigma Investments LP now owns 208,872 shares of the company’s stock worth $39,000 after acquiring an additional 62,284 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Vital Therapies by 99.7% in the fourth quarter. Geode Capital Management LLC now owns 682,934 shares of the company’s stock worth $127,000 after acquiring an additional 340,970 shares during the last quarter. 15.52% of the stock is currently owned by institutional investors.

Vital Therapies Company Profile (NASDAQ:VTL)

Vital Therapies, Inc, a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc in June 2003. Vital Therapies, Inc was founded in 2003 and is based in San Diego, California.

Further Reading: How is the Producer Price Index calculated?

Receive News & Ratings for Vital Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Therapies and related companies with MarketBeat.com's FREE daily email newsletter.